NPNadiya Pasyechko

Nadiya Pasyechko

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nadiya Pasyechko has a total of 122 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Correction: A collaborative genomics platform for type 1 diabetes in Eastern and Central Europe

    by Khrystyna Shchubelka, Walter W. Wolfsberger, Karolina Kulis, Obed A. Garcia, Sudip Sharma, Yaroslava Hasynets, Oleksandr Dubiv, Oleksii Kurutsa, Nadiia Shylova, Alina Huklyvska, et al.

  • Open Access

    Coexistence of primary hyperparathyroidism and papillary thyroid carcinoma. Clinical case

    by I. M. Deykalo, V. V. Bukata, N. V. Pasyechko

    Primary hyperparathyroidism, most commonly caused by a parathyroid adenoma, may coexist with papillary thyroid carcinoma. Although this combination is relatively rare, it has important clinical implications. This paper presents a clinical case of coexistence of a parathyroid adenoma and papillary thyroid carcinoma in a 55-year-old woman. The clinical presentation included symptoms of hypercalcemia, urolithiasis, and pathological fractures. Ultrasound (US) examination and fine-needle aspiration biopsy revealed a nodule in the right thyroid lobe suspicious for papillary carcinoma, as well as an adenoma of the left inferior parathyroid gland. Laboratory findings confirmed primary hyperparathyroidism. The patient underwent single-stage surgical treatment — total thyroidectomy with parathyroid adenoma excision. Histopathological examination confirmed papillary thyroid carcinoma (pT1a) and parathyroid adenoma. In the postoperative period, transient hypoparathyroidism developed and was successfully managed with medical therapy. The patient was classified as having a low risk of recurrence; radioiodine therapy was not performed. Follow-up evaluation demonstrated a stable condition without evidence of recurrence. This case highlights the importance of comprehensive evaluation of patients with nodular thyroid disease, including assessment of parathyroid gland function. Single-stage surgical management of combined pathology helps to avoid reoperations and reduces the risk of complications. The inclusion of parathyroid hormone, ionized calcium, and vitamin D measurements in the standard diagnostic algorithm facilitates timely detection of primary hyperparathyroidism and optimization of surgical strategy.

  • Open Access

    The impact of genetic and immunological factors on glycemic stability in patients with type 1 diabetes mellitus: the role of continuous glucose monitoring systems and artificial pancreas

    by T. I. Krytskyy, N. V. Pasyechko

    The aim — to evaluate the impact of genetic and immunological factors on glycemic stability in patients with type 1 diabetes using data from continuous glucose monitoring systems and artificial pancreas systems. Materials and methods. The study included 62 patients with type 1 diabetes who used CGM systems for at least 14 days. Patients were divided into two groups: a high genetic risk group, which included patients with HLA-DR3/DR4 alleles and ≥ 2 autoantibodies, and a low genetic risk group, which included patients without these markers. Glycemic control was assessed using Time in Range and coefficient of variation metrics, which reflect glucose level stability. Genetic and immunological markers were identified using polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay (ELISA). Results. Patients with high genetic risk had significantly lower TIR values (52.1±10.8%) than patients with low genetic risk (61.3±11.2%). Furthermore, the high-risk group exhibited higher glucose variability, as evidenced by an increased CV (39.2±6.5%), compared to the low-risk group (CV — 33.8±5.9%). Multivariate linear regression analysis showed that the presence of HLA-DR3/DR4 and ≥ 2 autoantibodies were independent predictors of reduced TIR and increased CV. Conclusions. Genetic factors have a significant impact on glycemic stability in patients with type 1 diabetes mellitus. Patients with high genetic risk, characterized by the presence of HLA-DR3/DR4 alleles and ³ 2 autoantibodies, demonstrated poorer glycemic control, including lower Time in Range and higher coefficient of variation. This highlights the importance of an individualized approach to treatment and monitoring of these patients. The use of CGM and APS technologies cannot fully compensate for the impact of genetic factors, requiring adjustments in insulin therapy and continuous monitoring.

  • Open Access

    A collaborative genomics platform for type 1 diabetes in Eastern and Central Europe

    by Khrystyna Shchubelka, Walter W. Wolfsberger, Karolina Kulis, Obed A. Garcia, Sudip Sharma, Yaroslava Hasynets, Oleksandr Dubiv, Oleksii Kurutsa, Nadiia Shylova, Alina Huklyvska, et al.

  • Open Access

    THE EFFECT OF CONTINUOUS GLUCOSE MONITORING ON GLYCAEMIC CONTROL AND CARDIOVASCULAR EVENTS IN PATIENTS WITH DIABETES AND CARDIOVASCULAR DISEASE DURING WAR

    by T. Krytskyy, N. Pasyechko, I.P. Savchenko, L. Naumova

    Resume. Diabetes mellitus is one of the biggest health problems worldwide, significantly increasing the risk of developing cardiovascular diseases. To maintain effective glycaemic control and prevent cardiovascular complications, especially in settings with limited access to medical resources, the role of emerging technologies such as continuous glucose monitoring is growing. This technology allows patients and doctors to monitor glucose levels in real time, which is important for ensuring stable treatment even in difficult conditions.The aim of the study is to evaluate the impact of continuous glucose monitoring on glycemic control indicators, particularly HbA1c dynamics, and cardiovascular events in patients with diabetes mellitus (DM) and concomitant cardiovascular pathology under the conditions of martial law in Ukraine. Materials and methods. A prospective single-center study included 100 patients with type 1 and type 2 diabetes who were treated in the endocrinology and cardiology department of the Ternopil Regional Clinical Hospital in 2023-2024. All patients were equipped with CGM systems. HbA1c, Time in Range (TIR), Time Above Range (TAR), Time Below Range (TBR), glycemic variability (%CV), frequency of hypoglycemic events, and cardiovascular events were evaluated.Results. After 12 weeks of CGM use, there was a statistically significant reduction in HbA1c (from 8.6% to 7.4%; p<0.001), an increase in TIR (from 51% to 72%; p<0.001), and a decrease in the frequency of hypoglycemic events and hospitalizations for acute cardiovascular events. The use of CGM was associated with a reduction in glycemic variability and subjective stress levels.Conclusions. Continuous glucose monitoring is an effective tool for improving diabetes control and preventing cardiovascular complications in high-risk patients under wartime conditions. The dynamics of HbA1c reflect the integrated positive impact of CGM on the glycemic profile.

  • Open Access

    The Quality of Life Assessment and Psychological and Emotional State of Patients with Diabetes Mellitus and Cardiovascular Disease in War Conditions

    by Taras Krytskyy, Nadiia Pasyechko, Liudmyla Naumova, Iryna Savchenko, Iryna Smachylo, Alla Khomitska

    Type 2 diabetes mellitus and cardiovascular diseases (CVDs) are among the most common chronic diseases that significantly impair patients’ quality of life and increase the risk of serious complications. The objective. To assess the psychoemotional state, in particular the level of anxiety, depressive symptoms, stress, and quality of life in patients with type 2 diabetes mellitus and CVDs. Materials and methods. The study was conducted at the endocrinology and cardiology departments of the Ternopil Regional Hospital from 2021 to 2024. The study involved 78 male patients aged 30 to 60 with type II diabetes and/or CVD. The psychological and emotional state was assessed using the GAD-7 (anxiety level), BDI (depressive symptoms) scales and the Holmes and Rahe methods for determining stress resistance. The quality of life of patients was assessed using the SF-36 questionnaire. Results. The results showed a significant decrease in quality of life and stress resistance, as well as an increase in depression and anxiety levels in patients with a combination of type 2 diabetes and CVD compared to patients suffering from only one of these diseases. Patients with comorbidities experienced a significant increase in psychological and emotional stress, indicating the need for a comprehensive approach to treatment, including psychological and emotional support. The psychological and emotional state of patients has a significant impact on their quality of life and the effectiveness of therapy. Conclusions. Increased levels of stress, depression, and anxiety contribute to the deterioration of patients’ overall condition, reduce their ability to cope with chronic diseases, and complicate treatment. It is necessary to integrate psychotherapeutic strategies into the therapeutic process. Further research should focus on the implementation of effective psychotherapeutic techniques aimed at reducing the psychoemotional burden in patients with comorbidities.

  • Open Access

    Innovative approaches to the management of patients with obstructive sleep apnea-hypopnea syndrome, obesity and hypertension

    by L.V. Radetska, A.I. Khomitska, T.I. Krytskyy, O.O. Chukur, A.O. Bob, N.V. Pasiechko, N.I. Yarema, L.V. Naumova

    Background. Obstructive sleep apnea-hypopnea syndrome (OSAHS) is characterized by recurrent episodes of partial or complete upper airway collapse during sleep that is highlighted by a reduction or complete cessation of airflow despite documented ongoing inspiratory efforts. There are some pharmacological treatments for daytime sleepiness caused by OSASH. Identifying and treating obstructive sleep apnea early is important to reduce the risks of future complications. The purpose of the study was to determine the functional state of the cardiovascular system and the oxygen state of body tissues in patients with OSAHS of varying severity. Materials and methods. The study included 109 participants (85 men and 24 women) aged 27 to 55 (mean of 46.4 ± 9.1) years. All patients were comparable in sex, age, anthropometric parameters, as well as in the history of hypertension and the level of office blood pressure and underwent a study of the oxygen state by pulse oximetry and oximetry. Results. Hypertension in patients with obstructive sleep apnea-hypopnea syndrome is more resistant to therapy. The degree of resistance depends on the severity of OSAHS. The analysis of daily blood pressure monitoring data in OSAHS revealed differences in the growth of mean blood pressure, hypertension time index and daily blood pressure profile. The degree of night blood pressure reduction in patients with severe OSAHS was lower, among them, individuals with non-dipper and night-peaker profiles predominated. Conclusions. In OSAHS, significant disorders of arterial and venous blood oxygenation were detected, which is confirmed by a reliable decrease in venous blood saturation (p < 0.01) and oxygen content in arterial blood (p < 0.01). The volume of oxygen consumed by peripheral tissues was significantly lower (p < 0.05) in patients with severe OSAHS.

  • Open Access

    ДОСЛІДЖЕННЯ ВПЛИВУ НЕФРОПРОТЕКТОРНОГО ЗБОРУ НА СТРУКТУРУ НИРОК ЩУРІВ З ЕКСПЕРИМЕНТАЛЬНОЮ ГЕНТАМІЦИНОВОЮ НЕФРОПАТІЄЮ

    by С. М. Марчишин, О. Г. Дорошенко, О. П. Андріїшин, Н. В. Пасєчко, І. П. Савченко, А. І. Хоміцька

    РЕЗЮМЕ. Захворювання нирок є однією з головних проблем охорони здоров’я та причиною 1,5 % усієї смертності у світі. Небезпечним ускладненням таких захворювань є гостра ниркова недостатність (ГНН). Окрім високої летальності, ГНН також асоціюється з розвитком хронічної хвороби нирок (ХХН). Серед причин поширеності зазначених захворювань особливе місце має сьогодні медикаментозна гостра ниркова недостатність (ГНН), особливо внаслідок впливу антибіотиків. Провідне місце серед лікарських препаратів, які чинять нефротоксичний вплив, належить антибіотикам групи аміноглікозидів. Найвираженішим нефротоксичним антибіотиком є гентаміцин. Цей препаратат найчастіше використовують як засіб для моделювання нефротоксичності у тварин. З метою запобігання ушкодження нирок та прогресування і хронізації захворювань застосовують нефропротектори. Як нефропротектори у комплексному лікуванні захворювань нирок використовують лікарські рослини, які містять комплекс БАР, що проявляють антиоксидантні, діуретичні, протизапальні, антибактеріальні, спазмолітичні, мембраностабілізувальні властивості, покращують кровообіг в нирках, швидкість фільтрації сечі тощо. Мета – вивчити коригуючий вплив нефропротекторного збору на мікроскопічну будову нирок та порівняти його ефективність із дією референс-препарату «Хофітол» за умов експериментального токсичного ураження нирок гентаміцином. Матеріал і методи. Нефропротекторні властивості досліджуваного збору вивчали на моделі гострого токсичного ураження нирок гентаміцином. Досліди проведено на статевозрілих щурах-самках масою 160–280 г із дотриманням вимог біоетики. Щурів виводили з досліду під легким тіопентал-натрієвим наркозом шляхом декапітації, виділяли нирки. Шматочки нирок фіксували у 10 % розчині формаліну, зневоднювали в розчинах етанолу різної концентрації та заливали у парафін. Зрізи фарбували гематоксиліном та еозином за методом Ван Гізон. Мікроскопічне вивчення мікропрепаратів проводили під мікроскопом Granum, мікрофотографування здійснювали цифровою відеокамерою Granum DСМ 310. Фотознімки обробляли на комп’ютері Pentium 2,4GHz за допомогою програми Toup View. Обговорення. Одержані морфологічні дані засвідчили, що досліджуваний нефропротекторний збір суттєво зменшує пошкоджувальну дію гентаміцину: зменшуються розміри уражених ділянок ниркової паренхіми, кровонаповнення ниркових тілець менше виражене, суттєво краще збережені нефроцити проксимальних, тонких і дистальних канальців та збірних проток (їх цитоплазма виглядає більш гомогенною, розміри і кількість вакуолей у ній суттєво менша). Особливо чітко це виражено в нирках тварин, які отримували більшу дозу рослинного збору. Висновки. 1. Гістологічні дослідження показали, що нефропротекторний збір у дозах 5 мл/кг і 10 мл/кг запобігає розвитку гентаміцин-індукованої нефропатії: зменшуються структурні зміни у тубулярній структурі звивистих канальців кіркових нефронів, збільшуються структурно інтактні ділянки кори нирок. Нефропротекторний збір в обох дозах покращував морфометричні показники стану кори нирок, але в дозі 10 мл/кг ці позитивні зміни були вираженішими. Цитопротективна дія досліджуваного збору на даній моделі ниркової патології має чіткий дозозалежний ефект. Нефропротекторний збір у дозі 10 мл/кг за цитозахисним...


  • Open Access

    Medical information retrieval systems in diabetes management

    by T.I. Krytskyy, N.V. Pasyechko, L.V. Naumova

    Background. Medical information retrieval is becoming more crucial as a way to support decision-making and improve access to knowledge and information for doctors and other specialists in the field. By the incorporation of medical domain knowledge for relevance evaluation, integrating the medical knowledge bases has the potential to enhance information retrieval performance. The system uses various search algorithms and techniques to provide accurate and comprehensive results to medical professionals and researchers. Medical information retrieval systems are particularly useful for healthcare providers who need to stay up-to-date with the latest medical research, guidelines, and treatment options. The purpose was to study the use of medical information systems to improve the quality of medical care for patients with diabetes. Materials and methods. To assess the relevance of research using information systems in the SCOPUS database, an analytical query was formulated: ALL (“Diabetes”) AND (ALL (“Constant monitoring of glucose”) OR ALL (“Coefficient of variability of glucose”) OR ALL (“Time in the given target range”) OR ALL (“Time above range”) OR ALL (“Time below range”) OR ALL (“Insulin pump”). A search query on this topic found 17,532 scientific papers from 1974 to 2023. Results. The largest number of literary sources on the researched topic falls on 2014–2023. During this period, 10,531 works were published. In 2014, 728 papers were published, and in 2023 — 1,499 papers, which confirms the constant growth of interest and relevance in improving medical care for patients with diabetes worldwide. Since the statistics show a steady annual increase in the number of patients with diabetes, the search for effective methods of control and treatment of this nosology is extremely urgent. Conclusions. The implementation of medical information systems in diabetology has significant potential and can significantly improve the control and management of the disease, increase not only the duration, but also the quality of life of patients and optimize the work of medical personnel.


  • Open Access

    Modern methods for assessing compensation of diabetes mellitus. Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes

    by N.V. Pasyechko, L.V. Naumova, T.I. Krytskyy, I.P. Savchenko

    Background. An integral part of diabetes mellitus (DM) management is its timely diagnosis. The reference method to study the quality of glycemic control is evaluating the level of glycated hemoglobin (HbA1c) as one of the most accessible and informative tools. However, the introduction of novel technologies, namely the use of continuous glucose monitoring (CGM), has given patients with DM, their relatives and healthcare professionals an access to new indicators of glycemic control such as time in range (TIR), time above range and time below range. These indicators are criteria for compensation of carbohydrate metabolism according to the 2023 American Diabetes Association guidelines. The purpose of the study was to compare the effectiveness of using glucometers and the FreeStyle Libre system for flash glucose monitoring in patients with DM. Materials and methods. An examination of 60 patients with type 2 DM who received insulin therapy was conducted. They were aged 45–65 years, with DM duration of 5 ± 2 years. All participants were divided into two equal groups of 30 people each. The first group consisted of patients with CGM devices, the second group used glucometers for daily glycemic control. Additional CGM parameters were used: glucose coefficient of variation, glucose management indicator, which shows the probable level of HbA1c. Results. When evaluating the data obtained from patients who used CGM, it is important to note their high adherence to the use of flash glucose monitoring. The use of CGM made it possible to achieve compensation of carbohydrate metabolism faster compared to patients who used glucometers to correct glycemia. Discontinuation of CGM resulted in poorer glycemic control. The obtained results prove that the compensation of patients depends primarily on their motivation, willingness to follow medical prescriptions, careful glycemic control, and compliance with medical recommendations. Conclusions. For better control of the DM course, patients should use CGM. In order to assess diabetes compensation, it is not enough to consider only TIR. Time below range indicating hypoglycemia, time above range indicating hyperglycemia, glucose management indicator should also be taken into account. Discontinuation of CGM resulted in a loss of approximately half of the initial TIR gain achieved while using CGM. CGM is more favored among patients than a 7-point self-monitoring of blood glucose.